Author Archives : Healthcore Admin


Primary care physician perspectives on basal insulin initiation and maintenance in patients with type 2 diabetes mellitus

Primary care physician perspectives on basal insulin initiation and maintenance in patients with type 2 diabetes mellitus   Read More

Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study Protocol

Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study Protocol   Read More

Personalized Care and the Role of Insulin as a Vehicle to Optimizing Treatments in Diabetes Care

Personalized Care and the Role of Insulin as a Vehicle to Optimizing Treatments in Diabetes Care   Read More

Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticaria

Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticaria   Read More

Occurrence of hemolytic reactions on the same day as immune globulin product administrations during 2008 to 2014

Occurrence of hemolytic reactions on the same day as immune globulin product administrations during 2008 to 2014   Read More

Occurrence of acute renal failure on the same day as immune globulin product administrations during 2008 to 2014

Occurrence of acute renal failure on the same day as immune globulin product administrations during 2008 to 2014   Read More

Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years

Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years   Read More

Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes

Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes   Read More

Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation

Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation   Read More

A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data

A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data   Read More